ROME: Intellectual property group Tekcapital said Dr Robert Clell Miller has been appointed to the board as a non-exec director with immediate effect.
Intellectual property group Tekcapital (LON:TEK) said Dr Robert Clell Miller has been appointed to the board as a non-exec director with immediate effect.
Clifford Gross, Tekcapital’s executive chairman, said: “We are delighted to add Dr Miller to the board and believe his addition will provide significant business, medical and scientific expertise for future evaluations of medical technology and their opportunities for industrial scale commercialisation”.
Miller, 52, a professor of radiation oncology, is vice chairman of the board of trustees of Mayo Clinic Health System – Albert Lea and Austin.
He is also currently editor in chief of the rare tumours medical journal in Italy and the ‘Advances in Radiation Oncology’ medical journal in the USA.
In addition to a medical degree, among his academic achievements, is an undergraduate degrees in business administration and engineering physics from the University of Tulsa, and an MBA from the University of Oxford, UK.
